Alastair Gray

• Economic evaluation of factorial randomised controlled trials: Challenges, methods and recommendations

  Dakin HA. and Gray A., (2017), Statistics in Medicine

• Delayed Hospital Discharges of Older Patients: A Systematic Review on Prevalence and Costs.

  Landeiro F. et al, (2017), Gerontologist

• Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC)

  Tsiachristas A. et al, (2017), Journal of Medical Screening

• Body mass index and healthcare costs: a systematic literature review of individual participant data studies

  Kent S. et al, (2017), Obesity Reviews

• Reducing social isolation and loneliness in older people: a systematic review protocol.

  Landeiro F. et al, (2017), BMJ Open, 7, e013778 - e013778

• Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations.

  Dakin, H and Gray, AM, (2017), Statistics in Medicine

• One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial.

  Gray AM. et al, (2017), Heart

• Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1 year outcomes in the Arterial Revascularization Trial (ART)

  Benedetto U. et al, (2017), European Journal of Cardio-Thoracic Surgery

• Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.

  J, Leal et al, (2017), BMJ Open

• Randomized trial of bilateral versus single internal-thoracic-artery grafts

  Taggart DP. et al, (2016), New England Journal of Medicine, 375, 2540 - 2549

• Costs, quality of life and cost-effectiveness of open and arthroscopic repair for rotator cuff tears: economic evaluation alongside the UKUFF trial

  Murphy JFE. et al, (2016), Bone and Joint Journal

• Cholesterol- and blood pressure-lowering drug use for secondary cardiovascular prevention in 2004 - 2013 Europe

  Mihaylova BN. et al, (2016), European Journal of Preventive Cardiology

• The Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin with Laropiprant on Health and Healthcare Costs

  Mihaylova BN. et al, (2016), Circulation: Cardiovascular Quality and Outcomes

• Reducing social isolation in older people: a systematic review protocol

  Filipa Landeiro et al, (2016), PROSPERO International prospective register of systematic reviews

• Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)

  Mihaylova B. et al, (2016), American Journal of Kidney Diseases

• A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial.

  Davies MJ. et al, (2016), Prev Med, 84, 48 - 56

• The impact of social isolation on delayed hospital discharges of older hip fracture patients and associated costs.

  Landeiro F. et al, (2016), Osteoporos Int, 27, 737 - 745

• Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement.

  Petrou S. et al, (2016), Qual Life Res, 25, 275 - 281

• Impact of hip fracture on hospital care costs: a population-based study.

  Leal J. et al, (2016), Osteoporos Int, 27, 549 - 558

• Impact of hip fracture on hospital care costs: a population-based study

  Leal J. et al, (2016), OSTEOPOROSIS INTERNATIONAL, 27, 549 - 558

• The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review.

  Morton RL. et al, (2016), Nephrol Dial Transplant, 31, 46 - 56

• The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literature.

  Rombach I et al, (2016), Qual Life Res

• Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.

  Morton RL. et al, (2016), Am J Kidney Dis, 67, 31 - 39

• Economic evaluation of healthcare interventions: Old and new directions

  Gray AM. and Wilkinson T., (2016), Oxford Review of Economic Policy, 32, 102 - 121

• Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.

  Petrou S. et al, (2015), J Med Econ, 18, 851 - 857

• The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.

  Petrou S. et al, (2015), Pharmacoeconomics, 33, 993 - 1011

• Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.

  Petrou S. et al, (2015), Pharmacoeconomics, 33, 985 - 991

• Mapping from the Parkinson's Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L: The Value of Mixture Models.

  Kent S. et al, (2015), Med Decis Making, 35, 902 - 911

• Clinical effectiveness and cost-effectiveness of open and arthroscopic rotator cuff repair [the UK Rotator Cuff Surgery (UKUFF) randomised trial].

  Carr AJ. et al, (2015), Health Technol Assess, 19, 1 - 218

• PREFERRED REPORTING ITEMS FOR STUDIES MAPPING ONTO PREFERENCE-BASED OUTCOME MEASURES: THE MAPS STATEMENT

  (2015), International Journal of Technology Assessment in Health Care

• Quantifying the healthcare costs of treating severely bleeding major trauma patients: a national study for England.

  Campbell HE. et al, (2015), Crit Care, 19

• Effects of on-pump and off-pump surgery in the Arterial Revascularization Trial.

  Taggart DP. et al, (2015), Eur J Cardiothorac Surg, 47, 1059 - 1065

• The CSAW Study (Can Shoulder Arthroscopy Work?) - a placebo-controlled surgical intervention trial assessing the clinical and cost effectiveness of arthroscopic subacromial decompression for shoulder pain: study protocol for a randomised controlled trial.

  Beard D. et al, (2015), Trials, 16

• IMPACT OF EDUCATIONAL ATTAINMENT ON HEALTH OUTCOMES IN MODERATE-TO-SEVERE CHRONIC KIDNEY DISEASE

  Morton RL. et al, (2015), NEPHROLOGY DIALYSIS TRANSPLANTATION, 30

• What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?

  Kent S. et al, (2015), BMC Nephrol, 16

• UK research spend in 2008 and 2012: comparing stroke, cancer, coronary heart disease and dementia.

  Luengo-Fernandez R. et al, (2015), BMJ Open, 5

• Cost-effectiveness of Community Treatment Orders (CTOs): Economic Evaluation of the OCTET Study

  Simon J. et al, (2015), JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 18, S36 - S36

• IMPACT OF HIP FRACTURE ON HOSPITAL CARE COSTS: A POPULATION BASED STUDY

  Leal J. et al, (2015), OSTEOPOROSIS INTERNATIONAL, 26, S55 - S55

• Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.

  Petrou S. et al, (2015), J Med Econ, 18, 851 - 857

• PREFERRED REPORTING ITEMS FOR STUDIES MAPPING ONTO PREFERENCE-BASED OUTCOME MEASURES: THE MAPS STATEMENT.

  Petrou S. et al, (2015), Int J Technol Assess Health Care, 31, 230 - 235

• Economic evaluation of healthcare interventions: Old and new directions

  Alastair M Gray and Thomas Wilkinson, (2015), Oxford Review of Economic Policy

• Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort: does the ADDITION validation add up?

  Gray A. et al, (2014), Value Health, 17, 895 - 896

• CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.

  Day J. et al, (2014), Trials, 15

• Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.

  PD Med Collaborative Group None. et al, (2014), Lancet, 384, 1196 - 1205

• The OxCAP-MH: a Novel, Multi-dimensional, Patient-Reported Capabilities Instrument for Mental Health Research and Policy

  Simon J. et al, (2014), JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 17, S21 - S21

• Can delaying the onset of type 2 diabetes be cost-effective?

  Gray AM. et al, (2014), DIABETOLOGIA, 57, S120 - S121

• Utility values among myopic patients in mainland China.

  Li S. et al, (2014), Optom Vis Sci, 91, 723 - 729

• Coronary artery bypass grafting in high-RISk patients randomised to off- or on-Pump surgery: a randomised controlled trial (the CRISP trial).

  Rogers CA. et al, (2014), Health Technol Assess, 18, v - 157

• Protocol for the United Kingdom Rotator Cuff Study (UKUFF): a randomised controlled trial of open and arthroscopic rotator cuff repair.

  Carr AJ. et al, (2014), Bone Joint Res, 3, 155 - 160

• The effect of diabetes complications on health-related quality of life: the importance of longitudinal data to address patient heterogeneity.

  Alva M. et al, (2014), Health Econ, 23, 487 - 500

• A randomised controlled trial of the clinical effectiveness and cost-effectiveness of different knee prostheses: the Knee Arthroplasty Trial (KAT).

  Murray DW. et al, (2014), Health Technol Assess, 18, 1 - viii

• Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.

  Primrose JN. et al, (2014), JAMA, 311, 263 - 270

• Operationalising the capability approach for outcome measurement in mental health research.

  Simon J. et al, (2013), Soc Sci Med, 98, 187 - 196

• Economic burden of cancer across the European Union: a population-based cost analysis.

  Luengo-Fernandez R. et al, (2013), Lancet Oncol, 14, 1165 - 1174

• Quality of life after TIA and stroke: ten-year results of the Oxford Vascular Study.

  Luengo-Fernandez R. et al, (2013), Neurology, 81, 1588 - 1595

• Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the oxford vascular study

  Luengo-Fernandez R. et al, (2013), Stroke, 44, 2854 - 2861

• Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study.

  Luengo-Fernandez R. et al, (2013), Stroke, 44, 2854 - 2861

• Population-based study of acute- and long-term care costs after stroke in patients with AF.

  Luengo-Fernandez R. et al, (2013), Int J Stroke, 8, 308 - 314

• UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82

  Hayes AJ. et al, (2013), Diabetologia

• Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data.

  Leal J. et al, (2013), Diabetes Care, 36, 1541 - 1546

• Effect of 3-5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: FACS randomized controlled trial.

  Mant D. et al, (2013), JOURNAL OF CLINICAL ONCOLOGY, 31

• Professor Gavin Mooney 1943-2012.

  Gray A. and McGuire A., (2013), Health Econ, 22, 371 - 372

• Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score.

  Dakin H. et al, (2013), Qual Life Res, 22, 683 - 694

• Hospitalization resource use and costs before and after TIA and stroke: results from a population-based cohort study (OXVASC).

  Luengo-Fernandez R. et al, (2013), Value Health, 16, 280 - 287

• Improving clinical reality in chronic obstructive pulmonary disease economic modelling : development and validation of a micro-simulation approach.

  Asukai Y. et al, (2013), Pharmacoeconomics, 31, 151 - 161

• A systematic review and critical assessment of health state utilities: weight change and type 2 diabetes mellitus.

  Doyle S. et al, (2012), Pharmacoeconomics, 30, 1133 - 1143

• A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke.

  Luengo-Fernandez R. et al, (2012), Stroke, 43, 3343 - 3351

• A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke

  Luengo-Fernandez R. et al, (2012), Stroke, 43, 3343 - 3351

• Antibiotic management and early discharge from hospital: an economic analysis.

  Gray A. et al, (2012), J Antimicrob Chemother, 67, 2297 - 2302

• Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation.

  Gray LJ. et al, (2012), Cardiovasc Diabetol, 11

• The effectiveness and cost of single and multi-factorial cardiovascular risk factor modification to guideline targets in type 2 diabetes.

  Prescott A. et al, (2012), Prim Care Diabetes, 6, 67 - 73

• Mobile phone use for contacting emergency services in life-threatening circumstances.

  Wu O. et al, (2012), J Emerg Med, 42, 291 - 298.e3

• Mobile phone use for contacting emergency services in life-threatening circumstances

  Wu O. et al, (2012), Journal of Emergency Medicine, 42, 291 - 298

• UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?

  Luengo-Fernandez R. et al, (2012), Eur J Neurol, 19, 149 - 154

• The Impact of Risk Management Standards on Patient Safety: The Determinants of MRSA Infections in Acute NHS Hospitals, 2001-08

  Fenn P. et al, (2012), Oxford Bulletin of Economics and Statistics

• The effectiveness and cost of single and multi-factorial cardiovascular risk factor modification to guideline targets in type 2 diabetes

  Prescott A. et al, (2012), Primary Care Diabetes

• Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis.

  Violato M. et al, (2012), PLoS One, 7

• Rationing of total knee replacement: a cost-effectiveness analysis on a large trial data set.

  Dakin H. et al, (2012), BMJ Open, 2

• Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score

  Dakin H. et al, (2012), Quality of Life Research, 1 - 12

• The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses.

  Campbell HE. et al, (2011), Eur J Cancer, 47, 2517 - 2530

• The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses

  Campbell HE. et al, (2011), European Journal of Cancer, 47, 2517 - 2530

• Cost-utility analysis of indacaterol in Germany: a once-daily maintenance bronchodilator for patients with COPD.

  Price D. et al, (2011), Respir Med, 105, 1635 - 1647

• Assessing the health benefits of tackling climate change.

  Charlesworth A. et al, (2011), BMJ, 343

• Patellar resurfacing in total knee replacement: five-year clinical and economic results of a large randomized controlled trial.

  Breeman S. et al, (2011), J Bone Joint Surg Am, 93, 1473 - 1481

• Economic evaluation using decision analytical modelling: Design, conduct, analysis, and reporting

  Petrou S. and Gray A., (2011), BMJ, 342

• Economic evaluation alongside randomised controlled trials: Design, conduct, analysis, and reporting

  Petrou S. and Gray A., (2011), BMJ, 342

• WITHDRAWN: Case management for people with severe mental disorders.

  Marshall M. et al, (2011), Cochrane Database Syst Rev

• Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting.

  Petrou S. and Gray A., (2011), BMJ, 342

• Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting.

  Petrou S. and Gray A., (2011), BMJ, 342

• Healthcare and social services resource use and costs of self-harm patients.

  Sinclair JM. et al, (2011), Soc Psychiatry Psychiatr Epidemiol, 46, 263 - 271

• Applied Methods of Cost-Effectiveness Analysis in Healthcare

  Gray AM. et al, (2011)

• MAVARIC - a comparison of automation-assisted and manual cervical screening: A randomised controlled trial

  Kitchener HC. et al, (2011), Health Technology Assessment, 15

• Cost of dementia in the pre-enlargement countries of the European Union.

  Luengo-Fernandez R. et al, (2011), J Alzheimers Dis, 27, 187 - 196

• Automation-assisted versus manual reading of cervical cytology (MAVARIC): a randomised controlled trial.

  Kitchener HC. et al, (2011), Lancet Oncol, 12, 56 - 64

• Assessing the health benefits of tackling climate change

  Charlesworth A. et al, (2011), BMJ, 343

• Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illness.

  Buchanan J. et al, (2010), PLoS One, 5

• Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART).

  Taggart DP. et al, (2010), Eur Heart J, 31, 2470 - 2481

• Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.

  Campbell HE. et al, (2010), Br J Cancer, 103, 776 - 786

• Diabetes: costs and cost-effectiveness.

  Gray AM., (2010), Diabet Med, 27, 971 - 972

• Enterprise liability, risk pooling, and diagnostic care

  Fenn P. et al, (2010), Journal of Public Administration Research and Theory, 20

• Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.

  Rivero-Arias O. et al, (2010), Med Decis Making, 30, 341 - 354

• Life expectancy in individuals with type 2 diabetes: implications for annuities.

  Price HC. et al, (2010), Med Decis Making, 30, 409 - 414

• Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey.

  Gray AM. and Papanicolas IN., (2010), BMC Health Serv Res, 10

• Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom.

  Rivero-Arias O. et al, (2010), Cost Eff Resour Alloc, 8

• Six year follow-up of a clinical sample of self-harm patients.

  Sinclair JM. et al, (2010), J Affect Disord, 121, 247 - 252

• The multinational nature of cost-effectiveness analyses alongside multinational clinical trials.

  Rivero-Arias O. and Gray A., (2010), Value Health, 13, 34 - 41

• An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.

  Campbell HE. et al, (2009), Br J Cancer, 101, 1074 - 1084

• UNDERSTANDING THE IMPACT OF STATIN TITRATION; A MODELLING APPROACH

  Gray AM. et al, (2009), VALUE IN HEALTH, 12, A313 - A313

• Modelling income group differences in the health and economic impacts of targeted food taxes and subsidies.

  Nnoaham KE. et al, (2009), Int J Epidemiol, 38, 1324 - 1333

• Obesity as market failure: Could a 'deliberative economy' overcome the problems of paternalism?

  Anand P. and Gray A., (2009), Kyklos, 62, 182 - 190

• The valuation of prenatal life in economic evaluations of perinatal interventions.

  Simon J. et al, (2009), Health Econ, 18, 487 - 494

• Development of life-expectancy tables for people with type 2 diabetes.

  Leal J. et al, (2009), Eur Heart J, 30, 834 - 839

• The costs and prognostic characteristics of ischaemic neurological deficit due to subarachnoid haemorrhage in the United Kingdom. Evidence from the MRC International Subarachnoid Aneurysm Trial.

  Rivero-Arias O. et al, (2009), J Neurol, 256, 364 - 373

• Statin cost-effectiveness in the United States for people at different vascular risk levels.

  Heart Protection Study Collaborative Group None., (2009), Circ Cardiovasc Qual Outcomes, 2, 65 - 72

• Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison.

  Luengo-Fernandez R. et al, (2009), Lancet Neurol, 8, 235 - 243

• From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gap.

  Legood R. et al, (2009), Health Policy, 89, 193 - 200

• Costs of stroke using patient-level data: a critical review of the literature.

  Luengo-Fernandez R. et al, (2009), Stroke, 40, e18 - e23

• Blood glucose self-monitoring in type 2 diabetes: A randomised controlled trial

  Farmer AJ. et al, (2009), Health Technology Assessment, 13

• Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.

  Farmer AJ. et al, (2009), Health Technol Assess, 13, iii - 50

• Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them

  Gray A. et al, (2009), BMJ (Online), 338, 215 - 218

• Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them.

  Gray A. et al, (2009), BMJ, 338

• The economic analyses of the UK prospective diabetes study.

  Gray AM. and Clarke P., (2008), Diabet Med, 25 Suppl 2, 47 - 51

• A cost-benefit analysis using contingent valuation techniques: a feasibility study in spinal surgery.

  Haefeli M. et al, (2008), Value Health, 11, 575 - 588

• Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial.

  Simon J. et al, (2008), BMJ, 336, 1177 - 1180

• Health Economics

  Gray AM., (2008), Evidence based Dementia Practice, 844 - 854

• Treatment pathways, resource use, and costs of endovascular coiling versus surgical clipping after aSAH.

  Wolstenholme J. et al, (2008), Stroke, 39, 111 - 119

• Cost-effectiveness of self-monitoring of blood glucose for the management of patients with non-insulin treated type 2 diabetes: economic evaluation of the DiGEM trial

  Simon J. et al, (2007), DIABETOLOGIA, 50, S431 - S431

• Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting.

  Mount Hood 4 Modeling Group None., (2007), Diabetes Care, 30, 1638 - 1646

• Cost-effectiveness analyses alongside randomised clinical trials

  Gray AM., (2006), Clinical Trials, 3, 538 - 542

• Population-based study of determinants of initial secondary care costs of acute stroke in the United Kingdom.

  Luengo-Fernandez R. et al, (2006), Stroke, 37, 2579 - 2587

• Estimating the association between SF-12 responses and EQ-5D utility values by response mapping.

  Gray AM. et al, (2006), Med Decis Making, 26, 18 - 29

• Cost-effectiveness analyses alongside randomised clinical trials.

  Gray AM., (2006), Clin Trials, 3, 538 - 542

• Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected

  Legood R. et al, (2005), International Journal of Cancer, 117, 981 - 987

• Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected.

  Legood R. et al, (2005), Int J Cancer, 117, 981 - 987

• Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).

  Clarke PM. et al, (2005), Diabetologia, 48, 868 - 877

• A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

  Clarke PM. et al, (2004), Diabetologia, 47, 1747 - 1759

• Valuing subjective vs objective risk reductions: An empirical analysis.

  Kennedy C. and Gray AM., (2004), RADIOTHERAPY AND ONCOLOGY, 72, S39 - S39

• A longitudinal study of the effects of age and time to death on hospital costs.

  Seshamani M. and Gray AM., (2004), J Health Econ, 23, 217 - 235

• New BMJ policy on economic evaluations. Economic evaluations should be judged on scientific merit.

  Gray AM. et al, (2003), BMJ, 326

• New BMJ policy on economic evaluations [1] (multiple letters)

  Craig D. et al, (2003), British Medical Journal, 326, 445 - 446

• The cost-effectiveness of residential radon remediation programmes: assumptions about benefits stream profiles over time.

  Kennedy CA. et al, (2002), J Environ Radioact, 59, 19 - 28

• Cost effectiveness analysis of radon remediation programmes.

  Kennedy CA. and Gray AM., (2001), Sci Total Environ, 272, 9 - 15

• The cost-effectiveness of radon-induced lung cancer prevention in schools

  Kennedy CA. and Gray AM., (2000), International Journal of Environmental Health Research, 10, 181 - 190

• A double-blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: a 3-year follow-up.

  Keoghane SR. et al, (2000), BJU Int, 85, 74 - 78

• The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: A review of the current literature.

  Rombach I. et al, Quality of Life Research

• Perceptions of Risks for Diabetes-Related Complications in Type 2 Diabetes Populations. A Systematic Review.

  Rouyard T. et al, Diabetic Medicine

• Pedicled and skeletonized single and bilateral internal mammary artery grafts 4 and the incidence of sternal wound complications: Insights from the Arterial 5 Revascularization Trial (ART)

  Benedetto B. et al, Journal of Thoracic and Cardiovascular Surgery

• How important is parameter uncertainty around the UK EQ-5D-3L value set when estimating treatment effects?

  Gray A. et al, Joint meeting of the Health Economists' Study Group and the Collège des économistes de la santé Aix-en-Provence, France, 11-13 January 2012

• Hospital costs in relation to body mass index in 1.1 million women in England: a prospective cohort study

  Kent S. et al, Lancet Public Health

• Cost-effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: a population based study

  leal J. et al, Journal of Bone and Mineral Research

• Cost effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let’s Prevent Diabetes cluster randomised controlled trial

  Leal J. et al, BMJ Open

• Cost effectiveness of a pragamatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the 'Let's Prevent Diabetes' cluster randomised controlled trial.

  Leal, J et al, BMJ Open

• A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease

  Schlackow I. et al, Heart

Key Publications

• Applied Methods of Cost-Effectiveness Analysis in Healthcare

  Gray AM. et al, (2011)

• UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82

  Hayes AJ. et al, (2013), Diabetologia

• Economic evaluation alongside randomised controlled trials: Design, conduct, analysis, and reporting

  Petrou S. and Gray A., (2011), BMJ, 342

• Rationing of total knee replacement: a cost-effectiveness analysis on a large trial data set.

  Dakin H. et al, (2012), BMJ Open, 2

Recent Publications

• Economic evaluation of factorial randomised controlled trials: Challenges, methods and recommendations

  Dakin HA. and Gray A., (2017), Statistics in Medicine

• Delayed Hospital Discharges of Older Patients: A Systematic Review on Prevalence and Costs.

  Landeiro F. et al, (2017), Gerontologist

• Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC)

  Tsiachristas A. et al, (2017), Journal of Medical Screening

• Body mass index and healthcare costs: a systematic literature review of individual participant data studies

  Kent S. et al, (2017), Obesity Reviews

• Reducing social isolation and loneliness in older people: a systematic review protocol.

  Landeiro F. et al, (2017), BMJ Open, 7, e013778 - e013778